Last Updated: September 24, 2026

CAM-METRAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cam-metrazine patents expire, and when can generic versions of Cam-metrazine launch?

Cam-metrazine is a drug marketed by Abc Holding, Camall, and Chartwell Rx. and is included in six NDAs.

The generic ingredient in CAM-METRAZINE is phendimetrazine tartrate. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cam-metrazine

A generic version of CAM-METRAZINE was approved as phendimetrazine tartrate by CHARTWELL on October 30th, 1991.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CAM-METRAZINE?
  • What are the global sales for CAM-METRAZINE?
  • What is Average Wholesale Price for CAM-METRAZINE?
Summary for CAM-METRAZINE
US Patents:0
Applicants:3
NDAs:6
Raw Ingredient (Bulk) Api Vendors: 1
DailyMed Link:CAM-METRAZINE at DailyMed

US Patents and Regulatory Information for CAM-METRAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abc Holding CAM-METRAZINE phendimetrazine tartrate TABLET;ORAL 085511-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx CAM-METRAZINE phendimetrazine tartrate TABLET;ORAL 085318-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Camall CAM-METRAZINE phendimetrazine tartrate TABLET;ORAL 085756-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx CAM-METRAZINE phendimetrazine tartrate TABLET;ORAL 083922-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.